Angiotensin‐converting enzyme inhibitors improve long‐term survival in patients with left
ventricular dysfunction after a myocardial infarction, but their mechanism of action is not …

Neuropeptide Y (NPY) has been shown to potentiate the effects of various vasoactive agents
in both in vitro and in vivo experiments. The present study was designed to investigate the …

Whereas the effects of cardiac transplantation on the catecholamine response to physical
exercise have been studied previously, the impact on psychological stress is unknown …

Previous studies have demonstrated that alpha-trinositol (D-myo-inositol-1.2. 6-
trisphosphate; PP56) may act as a functional neuropeptide Y (NPY) inhibitor. Because NPY …

Objective. The present study was performed to measure concentrations of plasma
noradrenaline and neuropeptide-Y-like immunoreactivity in relation to cardiac function in …

Hunting the Risk NPY and ACE Polymorphisms as Predictors of Cardiovascular Diseases:
Case Report and Review of the Literature Page 1 Internal Medicine: Open Access Lo Vasco …

Neuropeptide Y (NPY) is a co-transmitter of the sympathetic nervous system including the
renal nerves. The kidney expresses NPY receptors, which can also be activated by peptide …

Neuropeptide Y (NPY), a widely distributed peptide neurotransmitter, is implicated in both
the central and peripheral control of the cardiovascular system. Pathological changes in …

Giriş: Kalp yetmezliği (KY) kompleks nörohumoral ve inflamatuar bir sendromdur. Yapılan
çalışmalar proinflamatuar sitokinlerin kardiyak depresyona yol açarak kalbin sistolik ve/veya …

A pesar de los avances realizados en su tratamiento y el beneficio pronóstico asociado a
ello1, la insuficiencia cardiaca (IC) continúa presentando una elevada morbimortalidad2, 3 …